Hemophagocytic lymphohistiocytosis: A potentially underrecognized association with systemic inflammatory response syndrome, severe sepsis, and septic shock in adults

Chest

Volumn 140, Issue 4, 2011, Pages 933-938

  Raschke, Robert A ^a   Garcia Orr, Roxanne ^b  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b CARL T HAYDEN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYCLOSPORIN; ETOPOSIDE; HYPERTENSIVE FACTOR; IMMUNOGLOBULIN; STEROID;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; AUTOPSY; BONE MARROW BIOPSY; CASE REPORT; CLINICAL EVALUATION; CLINICAL FEATURE; CRITICALLY ILL PATIENT; DELIRIUM; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; HYPOTENSION; LABORATORY TEST; MALE; MEGAKARYOCYTE; MYELODYSPLASTIC SYNDROME; PATHOPHYSIOLOGY; PATIENT SATISFACTION; PLASMAPHERESIS; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; SEVERE SEPSIS; SYNDROME DELINEATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 80053483077     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-0619     Document Type: Article

References (49)

1. Henter JI, Horne A, AricóM, et al Histiocyte Society. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124-131. (Pubitemid 44958267)
2. Filipovich AH. Hemophagocytic lymphohistiocytosis and other hemophagocytic disorders. Immunol Allergy Clin North Am. 2008;28(2):293-313. (Pubitemid 351522416)
3. Emmenegger U, Schaer DJ, Larroche C, Neftel KA. Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly. 2005;135(21-22): 299-314. (Pubitemid 40942436)
4. Castillo L, Carcillo J. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med. 2009;10(3):387-392.
5. Gupta S, Weitzman S. Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy. Expert Rev Clin Immunol. 2010;6(1):137-154.
6. Filipovich A, McClain K, Grom A. Histiocytic disorders: recent insights into pathophysiology and practical guidelines. Biol Blood Marrow Transplant. 2010;16(suppl 1):S82-S89.
7. Janka G. Hemophagocytic lymphohistiocytosis: when the immune system runs amok. Klin Padiatr. 2009;221(5): 278-285.
8. Fox CP, Shannon-Lowe C, Gothard P, et al. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells. Clin Infect Dis. 2010;51(1):66-69.
9. Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C. Infections associated with haemophagocytic syndrome. Lancet Infect Dis. 2007;7(12):814-822. (Pubitemid 350152044)
10. Takahashi N, Chubachi A, Kume M, et al. A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases. Int J Hematol. 2001;74(2):209-213. (Pubitemid 33760074)
11. Voskoboinik I, Smyth MJ, Trapani JA. Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol. 2006;6(12):940-952. (Pubitemid 44851736)
12. Strauss R, Neureiter D, Westenburger B, Wehler M, Kirchner T, Hahn EG. Multifactorial risk analysis of bone marrow his-tiocytic hyperplasia with hemophagocytosis in critically ill medical patients - a postmortem clinicopathologic analysis. Crit Care Med. 2004;32(6):1316-1321. (Pubitemid 38738586)
13. Kuwata K, Yamada S, Kinuwaki E, Naito M, Mitsuya H. Peripheral hemophagocytosis: an early indicator of advanced systemic inflammatory response syndrome/hemophagocytic syndrome. Shock. 2006;25(4):344-350.
14. Stéphan F, Thiolière B, Verdy E, Tulliez M. Role of hemophagocytic histiocytosis in the etiology of thrombocytopenia in patients with sepsis syndrome or septic shock. Clin Infect Dis. 1997;25(5):1159-1164. (Pubitemid 27513204)
15. To KK, Hung IF, Li IW, et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis. 2010;50(6):850-859.
16. Henter JI, Chow CB, Leung CW, Lau YL. Cytotoxic therapy for severe avian influenza A (H5N1) infection. Lancet. 2006;367(9513):870-873.
17. Puente J, Carvajal T, Parra S, et al. In vitro studies of natural killer cell activity in septic shock patients. Response to a challenge with alpha-interferon and interleukin-2. Int J Clin Pharmacol Ther Toxicol. 1993;31(6):271-275. (Pubitemid 23187443)
18. Von Muller L, Klemm A, Durmus N, et al. Cellular immunity and active human cytomegalovirus infection in patients with septic shock. J Infect Dis. 2007;196(9):1288-1295. (Pubitemid 351412000)
19. Saito K, Wagatsuma T, Toyama H, et al. Sepsis is characterized by the increases in percentages of circulating CD4+CD25+ regulatory T cells and plasma levels of soluble CD25. Tohoku J Exp Med. 2008;216(1):61-68.
20. Nahum E, Ben-Ari J, Stain J, Schonfeld T. Hemophagocytic lymphohistiocytic syndrome: Unrecognized cause of multiple organ failure. Pediatr Crit Care Med. 2000;1(1):51-54.
21. Karapinar B, Yilmaz D, Balkan C, Akin M, Ay Y, Kvakli K. An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: hemophagocytic lymphohistiocytosis. Pediatr Crit Care Med. 2009;10(3):285-290.
22. Masri K, Mahon N, Rosario A, et al. Reactive hemophagocytic syndrome associated with disseminated histoplasmosis in a heart transplant recipient. J Heart Lung Transplant. 2003;22(4):487-491. (Pubitemid 36390238)
23. Bouffandeau B, Mofredj A, Blanc S. Hemophagocytic syndrome in the critically ill. Intensive Care Med. 2001;27(5):948-949.
24. Coca A, Bundy KW, Marston B, Huggins J, Looney RJ. Macrophage activation syndrome: Serological markers and treatment with anti-thymocyte globulin. Clin Immunol. 2009;132(1):10-18.
25. Arlet JB, Le TH, Marinho A, et al. Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature. Ann Rheum Dis. 2006;65(12):1596-1601. (Pubitemid 44799671)
26. Berry PA, Bernal W, Pagliuca A, et al. Multiple organ failure and severe bone marrow dysfunction in two 18 year-old Caucasian patients: Epstein-Barr virus and the haemophagocytic syndrome. Anaesthesia. 2008;63(11):1249-1254.
27. Spivack T, Chawla R, Marik PE. Epstein-Barr virus-associated hemophagocytic syndrome mimicking severe sepsis. J Emerg Trauma Shock. 2008;1(2):119-122.
28. Tanaka H, Nishimura T, Hakui M, Sugimoto H, Tanaka-Taya K, Yamanishi K. Human herpesvirus 6-associated hemophagocytic syndrome in a healthy adult. Emerg Infect Dis. 2002;8(1):87-88. (Pubitemid 34094290)
29. Srichaikul T, Punyagupta S, Mongkolsritrakul W, Jidpugdeebodin S. EBV and hemophagocytic syndrome: analysis of 3 cases, with speculation on clinical features, therapy and role of EBV. J Med Assoc Thai. 2004;87(8):974-983. (Pubitemid 39221720)
30. Segall L, Moal M-C, Doucet L, Kergoat N, Bourbigot B. Toxoplasmosis-associated hemophagocytic syndrome in renal transplantation. Transpl Int. 2006;19(1):78-80.
31. Sanada S, Ookawara S, Shindo T, Morino K, Ishikawa H, Suzuki M. A case report of the effect of plasma exchange on reactive hemophagocytic syndrome associated with toxic shock syndrome. Ther Apher Dial. 2004;8(6):503-506. (Pubitemid 40082561)
32. Goto S, Aoike I, Shibasaki Y, et al. A successfully treated case of disseminated tuberculosis-associated hemophagocytic syndrome and multiple organ dysfunction syndrome. Am J Kidney Dis. 2001;38(4) :E19.
33. Bhagwati NS, Oiseth SJ, Abebe LS, Wiernik PH. Intravascular lymphoma associated with hemophagocytic syndrome: a rare but aggressive clinical entity. Ann Hematol. 2004;83(4):247-250. (Pubitemid 38443511)
34. To K-F, Chan PKS, Chan KF, et al. Pathology of fatal human infection associated with avian influenza A H5N1 virus. J Med Virol. 2001;63(3):242-246. (Pubitemid 32116480)
35. Yuen KY, Chan PKS, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet. 1998;351(9101):467-471. (Pubitemid 28070092)
36. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet. 2005;365(453) :63-78.
37. Buyse S, Teixeira L, Galicier L, et al. Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med. 2010;36(10):1695-1702.
38. Voves C, Wuillemin WA, Zeerleder S. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients. Blood Coagul Fibrinolysis. 2006;17(6):445-451. (Pubitemid 44231689)
39. Samra JS, Summers LK, Frayn KN. Sepsis and fat metabolism. Br J Surg. 1996;83(9):1186-1196. (Pubitemid 26290442)
40. Spada PL, Rossi C, Alimonti A, et al. Ferritin iron content in haemodialysis patients: Comparison with septic and hemochromatosis patients. Clin Biochem. 2008;41(12):997-1001.
41. Baynes R, Bezwoda W, Bothwell T, Khan Q, Mansoor N. The non-immune inflammatory response: serial changes in plasma iron, iron-binding capacity, lactoferrin, ferritin and C-reactive protein. Scand J Clin Lab Invest. 1986;46(7):695-704. (Pubitemid 17171522)
42. Karras A, Thervet E, Legendre C;Groupe Coopératif de transplantation d'Ile de France. Hemophagocytic syndrome in renal transplant recipients: report of 17 cases and review of literature. Transplantation. 2004;77(2):238-243. (Pubitemid 38155753)
43. Ramanan AV, Schneider R. Macrophage activation syndrome-what's in a name! J Rheumatol. 2003;30(12):2513-2516.
44. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr. 2007;166(2):95-109. (Pubitemid 46025500)
45. Gupta A, Tyrrell P, Valani R, Benseler S, Weitzman S, Abdelhaleem M. The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008;51(3):402-404.
46. Baldwin EL, Osheroff N. Etoposide, topoisomerase II and cancer. Curr Med Chem Anticancer Agents. 2005;5(4): 363-372. (Pubitemid 40974810)
47. Imashuku S, Kuriyama K, Teramura T, et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol. 2001;19(10):2665-2673. (Pubitemid 32441371)
48. Imashuku S, Kuriyama K, Sakai R, et al. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: A report from the HLH study center. Med Pediatr Oncol. 2003;41(2):103-109. (Pubitemid 36858327)
49. Takimoto CH. Topoisomerase interactive agents. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia, PA:Lippincott Williams and Williams;2005:382-384.